Medicure Inc.
AMEX : MCU
TSX : MPH

Medicure Inc.

September 13, 2005 16:05 ET

Medicure to Host Conference Call to Discuss Phase II Matched Results

WINNIPEG, MANITOBA--(CCNMatthews - Sept. 13, 2005) - Medicure Inc. (TSX:MPH)(AMEX:MCU), a cardiovascular drug discovery and development company today announced it will host a conference call and webcast on Wednesday, September 14, 2005, to discuss the results from the Phase II MATCHED study. A news release will be issued in the morning of September 14, 2005, with the conference call and webcast taking place at 10:30 am Eastern Time.

CONFERENCE CALL AND WEBCAST DETAILS

Date: Wednesday, September 14, 2005

Time: 10:30 am Eastern Time

Telephone: 1-877-888-3855 (toll free) or 1-416-695-5261

Webcast: Will be available at the Medicure website at www.medicure.com

About Medicure Inc.

Medicure Inc. is a cardiovascular drug discovery and development Company focused on developing effective therapeutics for unmet needs in the field of cardiovascular medicine, the largest pharmaceutical market sector. The Company's solid position in this field is supported by the following attributes:

- Cardiovascular focused pipeline: a global market of over US $70 billion

- Two drugs - MC-1 & MC-4232 - in advanced clinical development

- Two positive Phase II trials completed

- Unique products addressing major, inadequately served markets

- Second combination product, MC-4262 is entering development stage

- Dual action antithrombotic, MC-45308, with positive preclinical results

Medicure also has a medicinal chemistry based Drug Discovery program focused on discovery and advancement of novel small molecule, anti-ischemics, and antithrombotics towards human clinical studies.

This press release contains forward-looking statements that involve risks, which may cause actual results to differ materially from the statements made, and accordingly may be deemed to be forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are made as of the date hereof, and the Company disclaims any intention and has no obligation or responsibility to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.



Contact Information

  • Medicure Inc.
    Derek Reimer
    Chief Financial Officer
    888-435-2220
    204-488-9823 (FAX)
    or
    Medicure Inc.
    Hogan Mullally
    Manager of Investor & Public Relations
    888-435-2220
    204-488-9823 (FAX)
    info@medicure.com
    www.medicure.com